18hon MSN
The Latest: Federal judge tosses Trump’s $15B defamation lawsuit against The New York Times
U.S. President Donald Trump is expected to talk with Chinese leader Xi Jinping on Friday in a push to finalize a deal to ...
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints.
As per the official notice, the NIOS Class 10 and 12 examinations are scheduled to be held from October 14 to November 18, 2025. There will be no change in the dates of the examination. Candidates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback